Rutgers researcher leads team analyzing more exact methods to diagnose the most common tick-borne infection
Researchers have developed techniques to detect Lyme disease bacteria weeks sooner than current tests, allowing patients to start treatment earlier.
The findings appear in the journal Clinical Infectious Diseases. The authors include scientists from Rutgers Biomedical and Health Sciences, Harvard University, Yale University, the National Institute of Allergy and Infectious Diseases, FDA, Centers for Disease Control and Prevention, and other institutions.
The new techniques can detect an active infection with the Lyme bacteria faster than the three weeks it takes for the current indirect antibody-based tests, which have been a standard since 1994. Another advantage of the new tests is that a positive result in blood indicates the infection is active and should be treated immediately, allowing quicker treatment to prevent long-term health problems. The techniques detect DNA or protein from the Lyme disease bacteria Borrelia burgdorferi.
“These direct tests are needed because you can get Lyme disease more than once, features are often nondiagnostic and the current standard FDA-approved tests cannot distinguish an active, ongoing infection from a past cured one,” said lead author Steven Schutzer, a physician-scientist at Rutgers New Jersey Medical School. “The problem is worsening because Lyme disease has increased in numbers to 300,000 per year in the United States and is spreading across the country and world.”
Lyme disease signs frequently, but not always, include a red ring or bull’s eye skin rash. When there is no rash, a reliable laboratory test is needed and preferably one that indicates active disease. The only FDA-approved Lyme disease tests rely on detecting antibodies that the body’s immune system makes in response to the disease. Such a single antibody test is not an active disease indicator but rather only an exposure indicator — past or present.
“The new tests that directly detect the Lyme agent’s DNA are more exact and are not susceptible to the same false-positive results and uncertainties associated with current FDA-approved indirect tests,” said Schutzer. “It will not be surprising to see direct tests for Lyme disease join the growing list of FDA-approved direct tests for other bacterial, fungal and viral infections that include Staphylococcus, Streptococcus, Candida, influenza, HIV, herpes and hepatitis, among others.”
The Latest on: Lyme disease
[google_news title=”” keyword=”Lyme disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Lyme disease
- Lyme Disease Newson September 26, 2023 at 5:00 pm
Apr. 21, 2023 — A majority of parents of children diagnosed with Lyme disease reported that their kids recovered within six months of completing antibiotic treatment, according to a new study.
- Penn Medicine develops mRNA vaccine against Lyme diseaseon September 26, 2023 at 4:29 pm
After showing promising results in preclinical trials, the experimental vaccine will be tested in clinical trials to assess safety and effectiveness in humans.
- Lyme disease vaccine study looking for participants at UW Healthon September 26, 2023 at 9:34 am
UW Health is looking for 75 people to test a new Lyme disease vaccine that targets more strains of the tick-borne illness than a little-used shot taken off the market more than 20 years ago.
- EXCL: Experimental new Lyme disease pill laces your skin with poisonon September 26, 2023 at 6:35 am
Researchers are working on a world-first pill to prevent Lyme disease in humans It is similar to the drug used to protect dogs and cats from ticks and fleas READ MORE: Pfizer's Lyme disease vaccine ...
- For 20 years, there has been no vaccine to treat Lyme disease. Here's why that may finally change.on September 22, 2023 at 12:48 pm
In order to get to that stage, roughly 18,000 volunteers, including adults and children will be followed by Pfizer over the next three years to see how well the vaccine prevents Lyme disease ...
- For 20 years, there has been no vaccine to treat Lyme disease. Here's why that may finally change.on September 22, 2023 at 12:14 pm
Lyme disease has been a problem across the country, including Connecticut, but for over 20 years no vaccine has been available. Pfizer could change that.
- Lyme disease: The pathogen's cunning strategies for persistent infection offer clues for vaccine developmenton September 22, 2023 at 8:29 am
Lyme disease is the leading vector-borne disease—meaning diseases that are transmitted to humans from another organism like a tick or mosquito—in North America and Europe.
- The first Lyme disease vaccine in 20 years is nearly here, and others may be on their wayon September 21, 2023 at 9:36 am
Cases of the tick-borne illness have surged in recent decades, prompting a push to develop new immunizations. A shot from Pfizer is in late clinical trials, and Penn Medicine is testing another ...
- Chris Meloni says family member's 1st signs of Lyme disease were confused for stomach fluon September 20, 2023 at 9:23 am
Chris Meloni says family member's 1st signs of Lyme disease were confused for stomach flu ...
- Vermonters can take part in a clinical study of a possible vaccine against Lyme diseaseon September 19, 2023 at 1:57 am
A worldwide Phase 3 clinical study of a possible vaccine for Lyme disease is underway and UVM Medical Center is one of the study sites.
via Bing News